FDA Adverse Event Malfunction Summary report: N

IVENIX, INC

MDR report key: 22702224 · Received August 4, 2025

Report

Report Number
3014732157-2025-00839
Event Type
Malfunction
Date Received
August 4, 2025
Date of Event
July 25, 2025
Report Date
September 24, 2025
Manufacturer
FRESENIUS KABI USA LLC
Product Code
FPA
UDI-DI
00811505030030
PMA / PMN Number
K183311
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
OTHER
Health Professional
N

Narratives

Description of Event or Problem · 0

THE FOLLOWING HAS BEEN REPORTED: NURSE REPORTED: "PT HAD PLATELETS ORDERED, RN WENT TO HANG PLATELETS. UPON PROGRAMMING PUMP AND GOING TO BACK PRIME SALINE INTO SECONDARY BLOOD TUBING IV PUMP BEEPED AND ALERTED PRIMARY OCCLUSION AND WOULDN'T BACK PRIME INTO BLOOD TUBING. ALL CLAMPS WERE OPEN. IV PUMP WAS TURNED OFF AND RESTARTED. ISSUE CONTINUED. IV PUMP WAS CHANGED, ISSUE CONTINUED. NEW BLOOD TUBING WAS PRIMED AND PROGRAMED INTO PUMP; ISSUE NO LONGER PERSISTED." INJURY/ADVERSE REACTION: NO. INFUSION STOPPAGE: NO. . A PRELIMINARY REVIEW IDENTIFIED THE FOLLOWING ISSUE: UNABLE TO PRIME AIR FROM TUBING SET. AN ACTIVE INFUSION WAS NOT STOPPED. REPORTING AS A CONSERVATIVE MEASURE. NO ADVERSE EFFECTS WERE REPORTED. ADDITIONAL INFORMATION IS NEEDED TO COMPLETE THE INVESTIGATION.

Description of Event or Problem · 0

FINDINGS: NO SAMPLE OR PICTURE AVAILABLE FOR ANALYSIS. NOTE: WITHOUT THE PROPER SAMPLE OR PICTURE EVALUATION IS NOT POSSIBLE TO DETERMINE THE PROBABLE ROOT CAUSE OF THE REPORTED FAILURE. CUSTOMER COMPLAINT CANNOT BE CONFIRMED. POTENTIAL ROOT CAUSES (PRIMING ERROR- IMPOSSIBLE TO BACKPRIME) COULD BE RELATED TO: EXCESS GLUE IN SECONDARY PORT CAUSING AND OBSTRUCTION. POTENTIAL ROOT CAUSES (OCCLUSION ALARM) COULD BE RELATED TO: KINKS LOCATED SOMEWHERE IN THE ADMIN SET. BLOCKAGE / OCCLUSIONS AT CONNECTIONS OR PORTS. SLIDE CLAMPS BEING ACTUATED ON THE TUBING. CURRENT PROCESS CONTROLS DETECTION (PRIMING ERROR- IMPOSSIBLE TO BACKPRIME): 100% LEAK AND OCCLUSION TEST ARE PERFORMED THROUGH THE LEAK AND OCCLUSION TEST MACHINE IN ORDER TO CAPTURE UNITS WITH ANY BLOCKAGE OR LEAK FAILURE MODE. QUALITY SAMPLING FOR FINAL PHYSICAL TESTING, FOR PERFORMING A FLOW AND UNDERWATER LEAK TESTS. 100% VISUAL INSPECTION DURING THE MANUFACTURING PROCESS AND FINAL PHYSICAL INSPECTIONS. CURRENT PROCESS CONTROLS DETECTION (OCCLUSION ALARM): 100% LEAK AND OCCLUSION TEST ARE PERFORMED THROUGH THE LEAK AND OCCLUSION TEST MACHINE IN ORDER TO CAPTURE UNITS WITH ANY BLOCKAGE OR LEAK FAILURE MODE. QUALITY SAMPLING FOR FINAL PHYSICAL TESTING, FOR PERFORMING A FLOW AND UNDERWATER LEAK TESTS. 100% VISUAL INSPECTION DURING THE MANUFACTURING PROCESS AND FINAL PHYSICAL INSPECTIONS. CODE NO.: SET-0014-20. BATCH NO.: FA24K0523. EXCEPTION GENERATED: THE BATCH RECORD FA24K0523 WAS REVIEWED. NO EXCEPTIONS WERE GENERATED THAT COULD CLASSIFY AS A POSSIBLE ROOT CAUSE OF THIS DEFECT. QUALITY TEST RESULTS: THE FINISHED GOOD LOT HAS PASSED ALL SAMPLING ACCEPTANCE CRITERIA FOR ALL TESTS PERFORMED INCLUDING IN-PROCESS TESTING AND PRODUCT TESTING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
231148 IVENIX, INC LVP BLOOD PRODUCTS ADMINISTRATION SET, DUAL-INLET, LOW-SORBING, Y-SITE, MESH FIL FPA FRESENIUS KABI USA LLC SET-0014-1 FA24K0523 00811505030030

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown